Dominick J Lemas1, Bridget E Young2, Peter R Baker3, Angela C Tomczik1, Taylor K Soderborg1, Teri L Hernandez4, Becky A de la Houssaye1, Charles E Robertson5, Michael C Rudolph6, Diana Ir5, Zachary W Patinkin2, Nancy F Krebs2, Stephanie A Santorico7, Tiffany Weir8, Linda A Barbour9, Daniel N Frank5, Jacob E Friedman10. 1. Sections of Neonatology. 2. Nutrition, and. 3. Clinical Genetics and Metabolism, Department of Pediatrics; 4. Divisions of Endocrinology, Metabolism, and Diabetes and College of Nursing; 5. Infectious Diseases, Department of Medicine; 6. Divisions of Endocrinology, Metabolism, and Diabetes and. 7. Human Medical Genetics and Genomics Program; and Department of Mathematical and Statistical Sciences, University of Colorado Denver, Denver, CO; and. 8. Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, CO. 9. Divisions of Endocrinology, Metabolism, and Diabetes and Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO; 10. Sections of Neonatology, Divisions of Endocrinology, Metabolism, and Diabetes and jed.friedman@ucdenver.edu.
Abstract
BACKGROUND: Increased maternal body mass index (BMI) is a robust risk factor for later pediatric obesity. Accumulating evidence suggests that human milk (HM) may attenuate the transfer of obesity from mother to offspring, potentially through its effects on early development of the infant microbiome. OBJECTIVES: Our objective was to identify early differences in intestinal microbiota in a cohort of breastfeeding infants born to obese compared with normal-weight (NW) mothers. We also investigated relations between HM hormones (leptin and insulin) and both the taxonomic and functional potentials of the infant microbiome. DESIGN: Clinical data and infant stool and fasting HM samples were collected from 18 NW [prepregnancy BMI (in kg/m(2)) <24.0] and 12 obese (prepregnancy BMI >30.0) mothers and their exclusively breastfed infants at 2 wk postpartum. Infant body composition at 2 wk was determined by air-displacement plethysmography. Infant gastrointestinal microbes were estimated by using 16S amplicon and whole-genome sequencing. HM insulin and leptin were determined by ELISA; short-chain fatty acids (SCFAs) were measured in stool samples by using gas chromatography. Power was set at 80%. RESULTS: Infants born to obese mothers were exposed to 2-fold higher HM insulin and leptin concentrations (P < 0.01) and showed a significant reduction in the early pioneering bacteria Gammaproteobacteria (P = 0.03) and exhibited a trend for elevated total SCFA content (P < 0.06). Independent of maternal prepregnancy BMI, HM insulin was positively associated with both microbial taxonomic diversity (P = 0.03) and Gammaproteobacteria (e.g., Enterobacteriaceae; P = 0.04) and was negatively associated with Lactobacillales (e.g., Streptococcaceae; P = 0.05). Metagenomic analysis showed that HM leptin and insulin were associated with decreased bacterial proteases, which are implicated in intestinal permeability, and reduced concentrations of pyruvate kinase, a biomarker of pediatric gastrointestinal inflammation. CONCLUSION: Our results indicate that, although maternal obesity may adversely affect the early infant intestinal microbiome, HM insulin and leptin are independently associated with beneficial microbial metabolic pathways predicted to increase intestinal barrier function and reduce intestinal inflammation. This trial was registered at clinicaltrials.gov as NCT01693406.
BACKGROUND: Increased maternal body mass index (BMI) is a robust risk factor for later pediatric obesity. Accumulating evidence suggests that human milk (HM) may attenuate the transfer of obesity from mother to offspring, potentially through its effects on early development of the infant microbiome. OBJECTIVES: Our objective was to identify early differences in intestinal microbiota in a cohort of breastfeeding infants born to obese compared with normal-weight (NW) mothers. We also investigated relations between HM hormones (leptin and insulin) and both the taxonomic and functional potentials of the infant microbiome. DESIGN: Clinical data and infant stool and fasting HM samples were collected from 18 NW [prepregnancy BMI (in kg/m(2)) <24.0] and 12 obese (prepregnancy BMI >30.0) mothers and their exclusively breastfed infants at 2 wk postpartum. Infant body composition at 2 wk was determined by air-displacement plethysmography. Infant gastrointestinal microbes were estimated by using 16S amplicon and whole-genome sequencing. HM insulin and leptin were determined by ELISA; short-chain fatty acids (SCFAs) were measured in stool samples by using gas chromatography. Power was set at 80%. RESULTS:Infants born to obese mothers were exposed to 2-fold higher HM insulin and leptin concentrations (P < 0.01) and showed a significant reduction in the early pioneering bacteria Gammaproteobacteria (P = 0.03) and exhibited a trend for elevated total SCFA content (P < 0.06). Independent of maternal prepregnancy BMI, HM insulin was positively associated with both microbial taxonomic diversity (P = 0.03) and Gammaproteobacteria (e.g., Enterobacteriaceae; P = 0.04) and was negatively associated with Lactobacillales (e.g., Streptococcaceae; P = 0.05). Metagenomic analysis showed that HM leptin and insulin were associated with decreased bacterial proteases, which are implicated in intestinal permeability, and reduced concentrations of pyruvate kinase, a biomarker of pediatric gastrointestinal inflammation. CONCLUSION: Our results indicate that, although maternal obesity may adversely affect the early infant intestinal microbiome, HM insulin and leptin are independently associated with beneficial microbial metabolic pathways predicted to increase intestinal barrier function and reduce intestinal inflammation. This trial was registered at clinicaltrials.gov as NCT01693406.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Sylvia H Ley; Anthony J Hanley; Mathew Sermer; Bernard Zinman; Deborah L O'Connor Journal: Am J Clin Nutr Date: 2012-02-29 Impact factor: 7.045
Authors: Julie Mirpuri; Megan Raetz; Carolyn R Sturge; Cara L Wilhelm; Alicia Benson; Rashmin C Savani; Lora V Hooper; Felix Yarovinsky Journal: Gut Microbes Date: 2013-09-25
Authors: John Penders; Carel Thijs; Cornelis Vink; Foekje F Stelma; Bianca Snijders; Ischa Kummeling; Piet A van den Brandt; Ellen E Stobberingh Journal: Pediatrics Date: 2006-08 Impact factor: 7.124
Authors: Janet G M Markle; Daniel N Frank; Steven Mortin-Toth; Charles E Robertson; Leah M Feazel; Ulrike Rolle-Kampczyk; Martin von Bergen; Kathy D McCoy; Andrew J Macpherson; Jayne S Danska Journal: Science Date: 2013-01-17 Impact factor: 47.728
Authors: A M Karvonen; A Hyvärinen; H Rintala; M Korppi; M Täubel; G Doekes; U Gehring; H Renz; P I Pfefferle; J Genuneit; L Keski-Nisula; S Remes; J Lampi; E von Mutius; J Pekkanen Journal: Allergy Date: 2014-06-13 Impact factor: 13.146
Authors: Jacob E Friedman; Bridget E Young; Dominick J Lemas; Linda A Barbour; Daniel N Frank; Stephanie A Santorico Journal: Am J Clin Nutr Date: 2017-01 Impact factor: 7.045
Authors: Réka A Vass; Edward F Bell; Tarah T Colaizy; Mendi L Schmelzel; Karen J Johnson; Jacky R Walker; Tibor Ertl; Robert D Roghair Journal: Pediatr Res Date: 2020-01-30 Impact factor: 3.756
Authors: Michael C Rudolph; Bridget E Young; Kristina Harris Jackson; Nancy F Krebs; William S Harris; Paul S MacLean Journal: J Mammary Gland Biol Neoplasia Date: 2016-10-28 Impact factor: 2.673
Authors: D Chan; S Goruk; A B Becker; P Subbarao; P J Mandhane; S E Turvey; D Lefebvre; M R Sears; C J Field; M B Azad Journal: Int J Obes (Lond) Date: 2017-08-14 Impact factor: 5.095
Authors: Stephanie R Wesolowski; Karim C El Kasmi; Karen R Jonscher; Jacob E Friedman Journal: Nat Rev Gastroenterol Hepatol Date: 2016-10-26 Impact factor: 46.802
Authors: Heidi Dutton; Sarah Jean Borengasser; Laura Marie Gaudet; Linda A Barbour; Erin Joanne Keely Journal: Med Clin North Am Date: 2018-01 Impact factor: 5.456